EIF4A3 and acute myeloid leukemia: Given the commonly occurring inter-tumoral heterogeneity of many genes’ expression, we next assessed the degree of eIF4A3 variability, allowing us to subdivide the AML cases into three subsets: those expressing low (the bottom 25%), medium (26–75%) or high (top 25%) levels, designated Low, Moderate and High, respectively (Fig. 1D).